PF-Atlas › Mechanisms › Senolytic — clears p16+/p21+ senescent cells, reduces SASP
Senolytic — clears p16+/p21+ senescent cells, reduces SASP in IPF
Mechanism of action · idiopathic pulmonary fibrosis
Overview
Senolytic — clears p16+/p21+ senescent cells, reduces SASP is a therapeutic target in idiopathic pulmonary fibrosis. PF-Atlas tracks 1 drug and 0 clinical trials acting through this mechanism.
Drugs targeting Senolytic — clears p16+/p21+ senescent cells, reduces SASP
Therapies
Medical disclaimer. This is a research summary, not medical advice.